Cargando…

Fingolimod inhibits multiple stages of the HIV-1 life cycle

Antiretroviral drugs that target various stages of the Human Immunodeficiency Virus (HIV) life cycle have been effective in curbing the AIDS epidemic. However, drug resistance, off-target effects of antiretroviral therapy (ART), and varying efficacy in prevention underscore the need to develop novel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Resop, Rachel S., Fromentin, Rémi, Newman, Daniel, Rigsby, Hawley, Dubrovsky, Larisa, Bukrinsky, Michael, Chomont, Nicolas, Bosque, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425850/ https://www.ncbi.nlm.nih.gov/pubmed/32790802 http://dx.doi.org/10.1371/journal.ppat.1008679

Ejemplares similares

Pharmacological Targeting of Sphingosine Kinases Impedes HIV-1 Infection of CD4 T Cells through SAMHD1 Modulation
por: Resop, Rachel S., et al.
Publicado: (2022)

Cold Atmospheric Plasma Inhibits HIV-1 Replication in Macrophages by Targeting Both the Virus and the Cells
por: Volotskova, Olga, et al.
Publicado: (2016)

136 HIV-1 Nef regulates activity of endoplasmic reticulum chaperone calnexin
por: Jennelle, Lucas, et al.
Publicado: (2014)

The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
por: Mousseau, Guillaume, et al.
Publicado: (2015)

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)

Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents
por: Sorensen, Eric S., et al.
Publicado: (2020)

Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART
por: Gantner, Pierre, et al.
Publicado: (2020)

The immunological synapse: the gateway to the HIV reservoir
por: Kulpa, Deanna A, et al.
Publicado: (2013)

DNA dependent protein kinase (DNA-PK) enhances HIV transcription by promoting RNA polymerase II activity and recruitment of transcription machinery at HIV LTR
por: Zicari, Sonia, et al.
Publicado: (2020)

Drug 9AA reactivates p21/Waf1 and Inhibits HIV-1 progeny formation
por: Wu, Weilin, et al.
Publicado: (2008)

HIV-1 Replication through hHR23A-Mediated Interaction of Vpr with 26S Proteasome
por: Li, Ge, et al.
Publicado: (2010)

Modulation of Cardiac Autonomic Function by Fingolimod Initiation and Predictors for Fingolimod Induced Bradycardia in Patients with Multiple Sclerosis
por: Li, Kai, et al.
Publicado: (2017)

Multiple Sclerosis Relapses Following Cessation of Fingolimod
por: Malpas, Charles B., et al.
Publicado: (2022)

Long-term changes of serum chemokine levels in vaccinated military personnel
por: Brichacek, Beda, et al.
Publicado: (2006)

Potent suppression of HIV viral replication by a novel inhibitor of Tat
por: Mousseau, Guillaume, et al.
Publicado: (2012)

Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy
por: Chiu, Chris Y., et al.
Publicado: (2023)

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2011)

Myeloid cells as target of fingolimod action in multiple sclerosis
por: Di Dario, Marco, et al.
Publicado: (2015)

An observational study of alemtuzumab following fingolimod for multiple sclerosis
por: Willis, Mark, et al.
Publicado: (2017)

Risk factors for fingolimod-induced lymphopenia in multiple sclerosis
por: Ohtani, Ryohei, et al.
Publicado: (2018)

Fingolimod-Associated Macular Edema in the Treatment of Multiple Sclerosis
por: Khan, Asma A, et al.
Publicado: (2023)

Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis
por: Gajofatto, Alberto, et al.
Publicado: (2015)

Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection
por: Pardons, Marion, et al.
Publicado: (2019)

Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes
por: Dufour, Caroline, et al.
Publicado: (2023)

Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study
por: Bigaut, Kévin, et al.
Publicado: (2022)

Inhibition of HIV Replication by Apolipoprotein A-I Binding Protein Targeting the Lipid Rafts
por: Dubrovsky, Larisa, et al.
Publicado: (2020)

Extracellular vesicles carrying HIV-1 Nef induce long-term hyperreactivity of myeloid cells
por: Dubrovsky, Larisa, et al.
Publicado: (2022)

Fingolimod (Gileyna, FTY720): Innovative treatment for multiple sclerosis
por: Pinki,, et al.
Publicado: (2011)

Safety and Efficacy of Fingolimod in Treatment-Naïve Multiple Sclerosis Patients
por: Marriott, James J.
Publicado: (2011)

Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients
por: Farrokhi, Mehrdad, et al.
Publicado: (2015)

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment
por: Vollmer, Brandi L., et al.
Publicado: (2018)

Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis
por: De Stefano, Nicola, et al.
Publicado: (2017)

Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis
por: Bascuñana, Pablo, et al.
Publicado: (2020)

Disseminated Histoplasmosis in a Patient With Multiple Sclerosis Treated With Fingolimod
por: Abrahamowicz, Aleksandra A., et al.
Publicado: (2021)

Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients
por: Ferraro, Diana, et al.
Publicado: (2021)

Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis
por: Vaheb, Saeed, et al.
Publicado: (2023)

Metabolomic Changes in Patients Affected by Multiple Sclerosis and Treated with Fingolimod
por: Murgia, Federica, et al.
Publicado: (2023)

Erratum for Dubrovsky et al., “Inhibition of HIV Replication by Apolipoprotein A-I Binding Protein Targeting the Lipid Rafts”
por: Dubrovsky, Larisa, et al.
Publicado: (2020)

Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy
por: Lee, Sulggi A., et al.
Publicado: (2016)

Real‐life long‐term effectiveness of fingolimod in Swiss patients with relapsing‐remitting multiple sclerosis
por: Zecca, C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1es0hoef36mnto3kvh66bhumtk